WO2005040807A3 - Swiprosin-2 as a breast cancer marker - Google Patents

Swiprosin-2 as a breast cancer marker Download PDF

Info

Publication number
WO2005040807A3
WO2005040807A3 PCT/EP2004/011601 EP2004011601W WO2005040807A3 WO 2005040807 A3 WO2005040807 A3 WO 2005040807A3 EP 2004011601 W EP2004011601 W EP 2004011601W WO 2005040807 A3 WO2005040807 A3 WO 2005040807A3
Authority
WO
WIPO (PCT)
Prior art keywords
breast cancer
swiprosin
diagnosis
cancer marker
sws2
Prior art date
Application number
PCT/EP2004/011601
Other languages
French (fr)
Other versions
WO2005040807A2 (en
Inventor
Gabriele Pestlin
Herbert Andres
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Werner Zolg
Original Assignee
Roche Diagnostics Gmbh
Hoffmann La Roche
Gabriele Pestlin
Herbert Andres
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Werner Zolg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh, Hoffmann La Roche, Gabriele Pestlin, Herbert Andres, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Werner Zolg filed Critical Roche Diagnostics Gmbh
Publication of WO2005040807A2 publication Critical patent/WO2005040807A2/en
Publication of WO2005040807A3 publication Critical patent/WO2005040807A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Abstract

The present invention relates to the diagnosis of breast cancer. It discloses the use of protein swiprosin-2 (SWS2) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring SWS2 in said sample. Measurement of SWS2 can, e.g., be used in the early detection or diagnosis of breast cancer.
PCT/EP2004/011601 2003-10-15 2004-10-15 Swiprosin-2 as a breast cancer marker WO2005040807A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023509 2003-10-15
EP03023509.7 2003-10-15

Publications (2)

Publication Number Publication Date
WO2005040807A2 WO2005040807A2 (en) 2005-05-06
WO2005040807A3 true WO2005040807A3 (en) 2005-06-16

Family

ID=34486070

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/011601 WO2005040807A2 (en) 2003-10-15 2004-10-15 Swiprosin-2 as a breast cancer marker

Country Status (1)

Country Link
WO (1) WO2005040807A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2004030615A2 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2004030615A2 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
COLLINS F S: "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 99, no. 26, 24 December 2002 (2002-12-24), pages 16899 - 16903, XP002298284, ISSN: 0027-8424 *
DATABASE UniProt [online] 28 February 2003 (2003-02-28), "EF-hand domain-containing protein 1 (Swiprosin 2) (PP3051).", XP002317844, retrieved from EBI accession no. UNIPROT:Q9BUP0 Database accession no. Q9BUP0 *
DUFFY M J: "CLINICAL USES OF TUMOR MARKERS: A CRITICAL REVIEW", CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, CRC PRESS, BACA RATON, FL, US, vol. 38, no. 3, June 2001 (2001-06-01), pages 225 - 262, XP009042383, ISSN: 1040-8363 *
SHERING STEPHEN G ET AL: "Peroperative CA 15-3 concentrations predict outcome of patients with breast carcinoma", CANCER, vol. 83, no. 12, 15 December 1998 (1998-12-15), pages 2521 - 2527, XP002317989, ISSN: 0008-543X *
UNTCH M ET AL: "Tumor markers in breast cancer", LABORATORIUMSMEDIZIN 2001 GERMANY, vol. 25, no. 9-10, 2001, pages 343 - 352, XP008043102, ISSN: 0342-3026 *

Also Published As

Publication number Publication date
WO2005040807A2 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
KR100711046B1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE554389T1 (en) APEX AS A MARKER FOR LUNG CANCER
WO2008021290A9 (en) Organ-specific proteins and methods of their use
WO2004055519A3 (en) Specific markers for pancreatic cancer
WO2010136163A8 (en) Secernin-1 as a marker for cancer
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
DE60325382D1 (en) METHOD FOR DIAGNOSIS OF NUTRIFICIAL CANCER
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2008072275A3 (en) Telematic system for using diagnostic reagent strips and method for acquiring calibration data
DE602004017317D1 (en) USE OF THE PROTEINS PROTEINASE 3 (PRN3) AND LEUKOCYTES ELASTATES INHIBITOR (ILEU) AS A MARKER FOR COLORECTAL CARCINOMAS
CA2524708A1 (en) Use of protein cellular retinoic acid-binding protein ii (crabp ii) as marker for breast cancer
WO2004113574A3 (en) Methods for disease screening
ATE353544T1 (en) USE OF THE PROTEIN MASP AS A MARKER FOR COLORECTAL CARCINOMA
ATE393393T1 (en) USE OF THE PROTEIN SPEE AS A MARKER FOR BREAST CANCER
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
WO2005124360A3 (en) Use of protein tebp as a marker for breast cancer
WO2005124354A3 (en) Use of protein ch10 as a marker for breast cancer
ATE410691T1 (en) USE OF THE PROTEASOME ACTIVATOR SUBUNITY 3 PROTEIN AS A MARKER FOR COLORECTAL CARCINOMA

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase